Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS)

132 filings reported holding CHRS - Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share as of Q3 2025.
Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) has 110 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 51,568,676 shares of 116,964,738 outstanding shares and own 44% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (10,459,986 shares), VANGUARD GROUP INC (10,321,107 shares), TANG CAPITAL MANAGEMENT LLC (5,097,362 shares), Kohlberg Kravis Roberts & Co. L.P. (3,036,076 shares), GEODE CAPITAL MANAGEMENT, LLC (2,741,226 shares), STATE STREET CORP (2,223,376 shares), CM Management, LLC (2,100,000 shares), C WorldWide Group Holding A/S (1,928,464 shares), PANAGORA ASSET MANAGEMENT INC (1,375,968 shares), and CHARLES SCHWAB INVESTMENT MANAGEMENT INC (993,092 shares).
This table shows the top 110 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.